Pharma Pulse: The $1.5 Billion Weight Management Gamble and a Cancer Prevention Breakthrough

Feb 16, 10:30 AM

Headliner
Share
Subscribe
In today’s Pharma Pulse, Eli Lilly amasses a record-breaking stockpile for its oral GLP-1, while new research reveals a 66% reduction in endometrial cancer risk for certain patients.
Share
Subscribe
Next
Pharma Pulse: Restoring Physician Focus
Top episodes
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce